ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ID Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10829
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy and other bio products. It provides vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s vector technology is used to develop drugs in the bio-business classes such as gene therapy, gene vaccine, antibody, protein production and gene function analysis, among others. The company develops gene therapies for cardiovascular, respiratory, autoimmune, ophthalmologic diseases, cancer, and others. Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer’s disease, tumor and Parkinson’s disease, among others. The company has operations in the US, Japan and China. ID Pharma is headquartered in Tokyo, Japan.

ID Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ID Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ID Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 11
Licensing Agreements 12
Q-State Biosciences Enters into Licensing Agreement with ID Pharma 12
Axol Boscience Enters into Licensing Ageement with ID Pharma 13
Elixirgen Enters into Licensing Agreement with ID Pharma 14
Mayo Clinic Enters into Licensing Agreement with ID Pharma 15
Newcells Biotech Enters into Licensing Agreement with ID Pharma 16
Minerva Biotech Enters into Licensing Agreement with ID Pharma 17
Medinet Enters into Licensing Agreement with ID Pharma 18
Kohjin Bio to Enter into Licensing Agreement with ID Pharma 19
Dnavec Enters into Licensing Agreement with Sumitomo Dainippon Pharma 20
DNAVEC Enters Into Licensing Agreement With RIKEN BioResource Center 21
ID Pharma Co Ltd – Key Competitors 22
ID Pharma Co Ltd – Key Employees 23
ID Pharma Co Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ID Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ID Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
ID Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 11
Q-State Biosciences Enters into Licensing Agreement with ID Pharma 12
Axol Boscience Enters into Licensing Ageement with ID Pharma 13
Elixirgen Enters into Licensing Agreement with ID Pharma 14
Mayo Clinic Enters into Licensing Agreement with ID Pharma 15
Newcells Biotech Enters into Licensing Agreement with ID Pharma 16
Minerva Biotech Enters into Licensing Agreement with ID Pharma 17
Medinet Enters into Licensing Agreement with ID Pharma 18
Kohjin Bio to Enter into Licensing Agreement with ID Pharma 19
Dnavec Enters into Licensing Agreement with Sumitomo Dainippon Pharma 20
DNAVEC Enters Into Licensing Agreement With RIKEN BioResource Center 21
ID Pharma Co Ltd, Key Competitors 22
ID Pharma Co Ltd, Key Employees 23
ID Pharma Co Ltd, Other Locations 24
ID Pharma Co Ltd, Joint Venture 24

List of Figures
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ID Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ID Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wanbury Ltd (WANBURY):企業の財務・戦略的SWOT分析
    Summary Wanbury Ltd (Wanbury) is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients. The company offers products such as Cpink tablet, rabiplus capsule, cdense tablets, gems, folinine softule, adtrol-plus soft gelatin capsule, cheer capsule and cheer syrup. It inc …
  • Ascent Solar Technologies Inc (ASTI):電力:M&Aディール及び事業提携情報
    Summary Ascent Solar Technologies, Inc. (Ascent solar) designs, develops and manufactures thin-film photovoltaic modules. It pioneered the thin-film copper-indium-gallium-diselenide (CIGS) photovoltaic technology. The company employs monolithic integration process, which helps improve efficiency and …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Mosman Oil & Gas Ltd (MSMN):石油・ガス:M&Aディール及び事業提携情報
    Summary Mosman Oil & Gas Ltd (MOG) is an oil and gas company. The company operates in the exploration, development, and production of oil and gas projects. Its projects include amadeus basin, welch permian basin, blackstone strategic alliance, strawn oil project, and arkoma stacked pay project. MOG’ …
  • Flisom AG:電力:M&Aディール及び事業提携情報
    Summary Flisom AG (Flisom) is a manufacturer and distributor of solar modules that produces and commercializes flexible solar modules based on CIGS photovoltaic technologies. The company offers products such as ultralight solar modules, thin film photovoltaic solar modules, lightweight solar modules …
  • Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …
  • Cross Country Healthcare Inc (CCRN):企業の財務・戦略的SWOT分析
    Cross Country Healthcare Inc (CCRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Protagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • Hochschild Mining plc:企業のM&A・事業提携・投資動向
    Hochschild Mining plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hochschild Mining plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • American International Group Inc:企業のM&A・事業提携・投資動向
    American International Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American International Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Schweizerische Rettungsflugwacht (Rega):企業の戦略的SWOT分析
    Schweizerische Rettungsflugwacht (Rega) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Western Gas Partners LP (WES):企業の財務・戦略的SWOT分析
    Summary Western Gas Partners LP (Western Gas), a subsidiary of Anadarko Petroleum Corp is an oil and gas company that acquires, owns, develops and operates midstream energy assets. The company's services include processing, compressing, gathering, treating and transporting natural gas, natural gas l …
  • Slavneft-Yaroslavnefteorgsintez (JNOS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Yaroslavnefteorgsintez (Slavneft-YANOS), a subsidiary of Slavneft, is an oil and gas company that offers refined petroleum products. The company offers products such as bitumen, motor gasoline, diesel fuel, jet fuel, motor oil, transmission oil, turbine oil, compressor oil, industri …
  • Energy Resources Conservation and Development Commission:企業の戦略的SWOT分析
    Energy Resources Conservation and Development Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios SALVAT SA (SALVAT) is a pharmaceutical company with focus on the development and commercialization of innovative medicines. The company manufactures drugs in various segments such as personal healthcare, digestive / metabolism, urological conditions, ophthalmological diseases, E …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆